Rajavelu Esther 4
4 · Spero Therapeutics, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Rajavelu Esther
See Remarks
Transactions
- Sale
Common Stock
2025-11-07$2.37/sh−40,270$95,440→ 869,450 total
Footnotes (1)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on November 13, 2023.